Navigation Links
Proton Pump Inhibitor DEXILANT(TM) (dexlansoprazole) Now Available in U.S. Pharmacies
Date:4/26/2010

"When a name change occurs, pharmacists are often the first group of health care professionals that is impacted," noted Marlowe Djuric Kachlic, Pharm.D., clinical assistant professor at University of Illinois at Chicago – College of Pharmacy. "The most important thing for patients, pharmacists and health care professionals to note is that DEXILANT is the same medication as KAPIDEX, with the same safety and efficacy profile."

Individuals and health care professionals who have questions about this name change should contact Takeda at 1-877-TAKEDA-7. Errors involving DEXILANT or any other products should be reported to the FDA MedWatch program online at www.fda.gov/medwatch.

About DEXILANT™ (dexlansoprazole) 30 mg and 60 mg delayed release capsules

DEXILANT is a proton pump inhibitor (PPI), which decreases acid production by turning off many of the acid pumps in the stomach, thus helping to protect the esophagus from acidic reflux so that esophageal inflammation can heal. DEXILANT combines an enantiomer of lansoprazole with a Dual Delayed Release™ (DDR) formulation designed to provide two separate releases of medication. DEXILANT, taken once daily, is approved for the healing of all grades of erosive esophagitis (EE) for up to eight weeks, maintaining healing of EE for up to six months, and treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD) for four weeks.

Important Safety Information

DEXILANT is contraindicated in patients with known hypersensitivity to any c
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Leading Varian-Equipped Proton Therapy Center Treats 100th Patient
2. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
3. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
4. Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
5. New Proton Therapy Equipment Enables More Tumors to be Treated
6. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
7. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
8. Neurocrine Advances VMAT2 Inhibitor Program
9. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
10. Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors
11. TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... and LONDON , July 14, 2014 ... IXICO plc (AIM: IXI) jointly announced today the formation ... companies. Dr. Edward Ashton , Ph.D., chief scientific ... have seven members. "The formation of this ... the international commercial and operational alliance we signed with ...
(Date:7/13/2014)... July 13, 2014  Eli Lilly and Company ... from its non-clinical study in genetically engineered mice ... the beta-amyloid antibody N3pG and beta-secretase inhibitor BACE ... more effective in removing clumps of amyloid-beta protein ... thought to lead to Alzheimer,s disease (AD) – ...
(Date:7/11/2014)... 2014 Patient engagement has become a ... are turning to an assortment of marketing activities ... of this evolving approach to patient engagement, marketers ... engage patients throughout their experiences with a disease ... mapping the patient journey and employing a consumer ...
Breaking Medicine Technology:VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Relieving Drug Market Analysis 2010-2025 , , , ... , Reports details , ... opportunities lie in this diverse market with high, growing demand worldwide? , , ...
... WESTLAKE VILLAGE, Calif. , May 4 ... provider of specialty physician consultations via telemedicine, announced today ... Organization,s 2010 Innovations in Healthcare ABBY Award.  SOC won ... category for their 24/7 teleneurology service that provides immediate ...
Cached Medicine Technology:Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 2Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 3Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 4Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 5Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 6Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 7Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 8Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 9Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 10Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 11Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 12Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 13Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 14Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 15Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 16Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 17Specialists On Call Wins 2010 Innovations in Healthcare ABBY Award 2
(Date:7/14/2014)... 2014 According to a recent ... have discovered a connection between women with high levels ... infertility. Although doctors have theorized about the role stress ... study to provide scientific support. , “Stress, if very ... Dr. Larry Barmat, an OB/GYN who specializes in reproductive ...
(Date:7/14/2014)... could lead to the next generation of treatments of ... when recently evolved genes are damaged, and cells have ... , Astrobiologists Dr Charley Lineweaver from The Australian National ... teamed up with oncologist Dr Mark Vincent from the ... , "The rapid proliferation of cancer cells is ...
(Date:7/14/2014)... 2014 Top nutritional supplement provider ... Quality Control and Assurance Department. As the company continues ... highly-qualified quality assurance (QA) and quality control (QC) officers ... IQ Formulations has become known. , IQ ... of stellar experience and qualifications to their new positions ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 Secure Decisions, ... security, is partnering with the Software Assurance Marketplace (SWAMP) ... improve the software that drives everyday life. , The ... and housed in the Morgridge Institute for Research, is ... to advance software security practices by building a free ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, ... that a faltering sense of smell might signal the ... low-tech smell test could spot who needs more extensive ... decreased ability to identify odors was associated with the ... disease. "We,re trying to be able to diagnose ...
Breaking Medicine News(10 mins):Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:New theory turns cancer on its head 2Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... research has shown for the first time that omega-3 in ... symptoms of osteoarthritis. According to the University of Bristol ... journal Osteoarthritis and Cartilage , omega-3-rich diets fed to ... per cent compared to a standard diet. The research ...
... 2011 Dr. Michio Kaku, renowned futurist, theoretical physicist, ... keynote speaker at TCT, on Wednesday November 9 at ... Humankind." TCT 2011 Transcatheter Cardiovascular Therapeutics is ... sponsored by the Cardiovascular Research Foundation. More than ...
... for bowel disease is to be set up in London to ... innovation. Building of the 3 million centre of excellence has ... up and running in early 2012. The aim is ... way new surgical breakthroughs are rolled out to hospitals all over ...
... food and drink consumption, smoking and exercise habits. General ... "I only have a few drinks rarely...each week" and ... based on symptoms and a person,s physical appearance just ... for healthcare research and epidemiology that relies on patient ...
... By Jenifer Goodwin HealthDay Reporter , SATURDAY, ... seen in hospital emergency departments don,t believe their weight poses ... never told them otherwise, a new study finds. Researchers ... emergency department at Shands at the University of Florida two ...
Cached Medicine News:Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Omega-3 fatty acids shown to prevent or slow progression of osteoarthritis 2Health News:New national research center for bowel disease in London will be a UK first 2Health News:New national research center for bowel disease in London will be a UK first 3Health News:New national research center for bowel disease in London will be a UK first 4Health News:Avoiding bias in medical research 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4